The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic Radiopharmaceuticals Market Research Report 2025
Synopsis
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global Therapeutic Radiopharmaceuticals market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Radiopharmaceuticals.
Report Scope
The Therapeutic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global Therapeutic Radiopharmaceuticals market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Radiopharmaceuticals.
Report Scope
The Therapeutic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Therapeutic Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Therapeutic Radiopharmaceuticals
1.2 Therapeutic Radiopharmaceuticals Segment by Type
1.2.1 Global Therapeutic Radiopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Radiopharmaceuticals Segment by Application
1.3.1 Global Therapeutic Radiopharmaceuticals Market Value by Application: (2024-2030)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Radiopharmaceuticals Revenue 2019-2030
1.4.2 Global Therapeutic Radiopharmaceuticals Sales 2019-2030
1.4.3 Global Therapeutic Radiopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic Radiopharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Radiopharmaceuticals, Product Type & Application
2.7 Therapeutic Radiopharmaceuticals Market Competitive Situation and Trends
2.7.1 Therapeutic Radiopharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Radiopharmaceuticals Players Market Share by Revenue
2.7.3 Global Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Therapeutic Radiopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Radiopharmaceuticals Global Therapeutic Radiopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Therapeutic Radiopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Therapeutic Radiopharmaceuticals Sales by Region: 2025-2030
3.3 Global Therapeutic Radiopharmaceuticals Global Therapeutic Radiopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Therapeutic Radiopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Radiopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Radiopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Therapeutic Radiopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Therapeutic Radiopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Radiopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Therapeutic Radiopharmaceuticals Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Therapeutic Radiopharmaceuticals Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 China Isotope & Radiation
6.3.1 China Isotope & Radiation Corporation Information
6.3.2 China Isotope & Radiation Description and Business Overview
6.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Portfolio
6.3.5 China Isotope & Radiation Recent Developments/Updates
6.4 Dongcheng
6.4.1 Dongcheng Corporation Information
6.4.2 Dongcheng Description and Business Overview
6.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dongcheng Therapeutic Radiopharmaceuticals Product Portfolio
6.4.5 Dongcheng Recent Developments/Updates
6.5 Q BioMed
6.5.1 Q BioMed Corporation Information
6.5.2 Q BioMed Description and Business Overview
6.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Q BioMed Therapeutic Radiopharmaceuticals Product Portfolio
6.5.5 Q BioMed Recent Developments/Updates
6.6 Curium Pharmaceuticals
6.6.1 Curium Pharmaceuticals Corporation Information
6.6.2 Curium Pharmaceuticals Description and Business Overview
6.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Portfolio
6.6.5 Curium Pharmaceuticals Recent Developments/Updates
6.7 Jubilant Radiopharma
6.6.1 Jubilant Radiopharma Corporation Information
6.6.2 Jubilant Radiopharma Description and Business Overview
6.6.3 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product Portfolio
6.7.5 Jubilant Radiopharma Recent Developments/Updates
6.8 Lantheus
6.8.1 Lantheus Corporation Information
6.8.2 Lantheus Description and Business Overview
6.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lantheus Therapeutic Radiopharmaceuticals Product Portfolio
6.8.5 Lantheus Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aurobindo Pharma Therapeutic Radiopharmaceuticals Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 International Isotopes
6.10.1 International Isotopes Corporation Information
6.10.2 International Isotopes Description and Business Overview
6.10.3 International Isotopes Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 International Isotopes Therapeutic Radiopharmaceuticals Product Portfolio
6.10.5 International Isotopes Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Corporation Information
6.11.2 Mundipharma Therapeutic Radiopharmaceuticals Description and Business Overview
6.11.3 Mundipharma Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mundipharma Therapeutic Radiopharmaceuticals Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Radiopharmaceuticals Industry Chain Analysis
7.2 Therapeutic Radiopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Radiopharmaceuticals Production Mode & Process
7.4 Therapeutic Radiopharmaceuticals Sales and Marketing
7.4.1 Therapeutic Radiopharmaceuticals Sales Channels
7.4.2 Therapeutic Radiopharmaceuticals Distributors
7.5 Therapeutic Radiopharmaceuticals Customers
8 Therapeutic Radiopharmaceuticals Market Dynamics
8.1 Therapeutic Radiopharmaceuticals Industry Trends
8.2 Therapeutic Radiopharmaceuticals Market Drivers
8.3 Therapeutic Radiopharmaceuticals Market Challenges
8.4 Therapeutic Radiopharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
